InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-3.9%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Runge Marschall S, 董事. Director active across 1 company, notably ELI LILLY & Co. Aggregated, 4 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €44k. History available since 15 November 2021. The latest transaction was filed on 20 November 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Runge Marschall S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
335 股@ US$597.6025.9% 占其流量Common StockSEC:0000059478-23-000310:0
498 股@ US$361.1724.6% 占其流量Common StockSEC:0000059478-22-000261:0
202 股@ US$246.788.0% 占其流量Common StockSEC:0000059478-22-000092:0
标准退出：2022年5月30日 (T+90)
677 股@ US$258.4327.6% 占其流量Common StockSEC:0000059478-21-000222:0
4 条申报中的 4 条
About Runge Marschall S
Marschall S. Runge is a Board Member of Eli Lilly & Co. He brings his expertise to the board, contributing to strategic decision-making for the company. His experience in the pharmaceutical sector is valuable for guiding management.
